Invesco Biotechnology & Genome ETF (PBE) Chart & Stock Price History $68.20 -0.26 (-0.38%) Closing price 08/28/2025 04:10 PM EasternExtended Trading$68.17 -0.03 (-0.04%) As of 08/28/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Biotechnology & Genome ETF Stock Price Performance The Invesco Biotechnology & Genome ETF (PBE) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 5.05%, with a year-to-date return of 2.51%. In the past month, the fund has increased 3.44%, reflecting recent market activity. As of the latest close, Invesco Biotechnology & Genome ETF traded at $68.20 with a market cap of $235.29 million and volume of 6,276 shares. Five years ago, the fund traded at $58.00, representing a 17.59% increase over that period. At the time, it had a market cap of $230.23 million and a volume of 7,758 shares. Receive PBE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.93%1 Month Performance+3.44%3 Month Performance+7.55%Year-To-Date Performance+2.51%1 Year Performance-5.05%5 Year Performance+17.59% PBE Stock Chart for Friday, August, 29, 2025 PBE Chart by TradingView Invesco Biotechnology & Genome ETF Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/28/2025$68.46$68.20-0.38%$68.50$67.996,276 shs$235.29 million08/27/2025$67.86$68.46+0.88%$68.53$67.629,088 shs$236.19 million08/26/2025$67.58$67.86+0.41%$67.86$67.568,192 shs$234.12 million08/25/2025$68.84$67.58-1.83%$68.80$67.419,145 shs$233.15 million08/22/2025$68.28$68.84+0.82%$69.50$68.4119,589 shs$237.50 million08/21/2025$68.07$68.28+0.31%$68.50$67.938,809 shs$235.57 million08/20/2025$67.68$68.07+0.58%$68.10$67.718,066 shs$234.84 million08/19/2025$67.68$67.68$68.15$67.6511,448 shs$233.50 million08/18/2025$67.81$67.68-0.19%$68.34$67.628,319 shs$233.50 million08/15/2025$67.18$67.81+0.94%$67.82$67.059,977 shs$233.94 million Get the Latest News and Ratings for PBE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. 08/14/2025$67.67$67.18-0.72%$67.18$66.819,080 shs$231.77 million08/13/2025$66.04$67.67+2.47%$67.67$66.422,697 shs$233.46 million08/12/2025$64.95$66.04+1.68%$66.13$65.49204,758 shs$227.84 million08/11/2025$64.94$64.95+0.02%$65.42$64.788,226 shs$224.08 million08/08/2025$64.95$64.94-0.02%$65.29$64.795,193 shs$224.04 million08/07/2025$65.14$64.95-0.29%$65.18$64.607,466 shs$224.08 million08/06/2025$66.04$65.14-1.36%$65.89$64.926,223 shs$224.73 million08/05/2025$66.52$66.04-0.72%$66.41$65.8310,197 shs$227.84 million08/04/2025$65.54$66.52+1.50%$66.56$65.589,236 shs$229.49 million08/01/2025$65.30$65.54+0.37%$65.68$64.756,231 shs$226.11 million07/31/2025$65.85$65.30-0.84%$66.54$65.157,705 shs$225.29 million07/30/2025$65.93$65.85-0.12%$66.60$65.853,670 shs$227.18 million07/29/2025$65.85$65.93+0.12%$66.19$65.803,834 shs$227.46 million07/28/2025$66.59$65.85-1.11%$66.49$64.975,527 shs$227.18 million Related Companies XPH Stock Chart PJP Stock Chart CURE Stock Chart XHE Stock Chart PSCH Stock Chart PINK Stock Chart PTH Stock Chart KURE Stock Chart BBH Stock Chart SBIO Stock Chart Receive PBE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:PBE) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access